Option Care Health, Inc. $OPCH Stock Position Raised by Fifth Third Bancorp

Fifth Third Bancorp increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 3,855.4% during the first quarter, HoldingsChannel reports. The firm owned 92,082 shares of the company’s stock after acquiring an additional 89,754 shares during the period. Fifth Third Bancorp’s holdings in Option Care Health were worth $2,479,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in OPCH. Cornerstone Investment Partners LLC increased its holdings in shares of Option Care Health by 3.4% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company’s stock valued at $311,000 after purchasing an additional 318 shares during the period. Sheets Smith Wealth Management lifted its position in shares of Option Care Health by 1.3% in the fourth quarter. Sheets Smith Wealth Management now owns 26,167 shares of the company’s stock worth $834,000 after buying an additional 326 shares during the last quarter. UMB Bank n.a. lifted its holdings in Option Care Health by 23.5% in the 4th quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock worth $55,000 after purchasing an additional 326 shares during the last quarter. Andina Capital Management LLC lifted its stake in shares of Option Care Health by 2.6% in the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock worth $520,000 after buying an additional 419 shares during the last quarter. Finally, ProShare Advisors LLC lifted its position in Option Care Health by 1.3% during the 4th quarter. ProShare Advisors LLC now owns 35,533 shares of the company’s stock worth $1,132,000 after acquiring an additional 444 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on OPCH. Stephens reissued an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a research report on Friday. Morgan Stanley set a $28.00 price objective on Option Care Health in a research note on Wednesday, May 6th. UBS Group reiterated a “buy” rating on shares of Option Care Health in a research report on Tuesday, June 16th. JPMorgan Chase & Co. cut their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Finally, Truist Financial set a $30.00 target price on shares of Option Care Health in a research report on Friday, May 1st. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $30.08.

Option Care Health Stock Down 0.4%

Shares of Option Care Health stock opened at $21.67 on Wednesday. The business has a 50-day moving average of $21.23 and a two-hundred day moving average of $27.32. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The company has a market capitalization of $3.40 billion, a P/E ratio of 16.80, a price-to-earnings-growth ratio of 1.21 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same period last year, the company posted $0.40 EPS. The business’s quarterly revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities analysts predict that Option Care Health, Inc. will post 1.64 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average price of $21.41 per share, with a total value of $783,820.10. Following the acquisition, the director directly owned 450,000 shares of the company’s stock, valued at $9,634,500. The trade was a 8.86% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders have bought 73,264 shares of company stock worth $1,548,316. Corporate insiders own 1.70% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.